ClinicalTrials.gg
Sign In
CompletedNCT02098694Updated Jun 9, 2020

Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis

An interventional study of Physiotherapy follow-up in Spondylarthritis, Spondylitis, Ankylosing and Spondylarthropathies, sponsored by Norwegian University of Science and Technology. Completed at 1 site in Norway. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2020-06-09.

Primary conditionSpondylarthropathiesRegistry: SpondylarthritisReclassifiedWhy we changed it
Registry
Spondylarthritis — the first condition term the registry derived for this study.
ClinicalTrials.gg
Spondylarthropathies
Why
  1. The study's listed conditions name Spondylarthropathies, a narrower term within Spondylarthritis.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

The purpose of this study is to determine whether patients with spondyloarthritis are more satisfied with a physiotherapy-led outpatient clinic than usual care and whether there is a difference between patients in a physiotherapy-led outpatient clinic and those in usual care regarding disease activity, function and mobility.

02

Conditions studied

  • Spondylarthritis
  • Spondylitis, Ankylosing
  • Spondylarthropathies
  • Sacroiliitis
  • Arthritis, Psoriatic

Keywords

  • Physiotherapy
  • Outpatient clinic
03

In context

Spondylarthropathies Reclassified

68 studies on the registry are indexed under Spondylarthropathies; 10 are open to participants now.

This study's enrollment of 62 is below the median of 103 across 40 interventional studies indexed under Spondylarthropathies.

Browse Spondylarthropathies studies →

Lead sponsor

Norwegian University of Science and Technology is the lead sponsor of 495 studies on the registry; 48 are open to participants now.

Browse Norwegian University of Science and Technology studies →

Compared within Spondylarthropathies, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Spondylarthritis. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • confirmed diagnosis spondyloarthritis, ankylosing spondylitis, spondylarthropathy, juvenile ankylosing spondylitis, psoriatic arthritis with affection of the spine
  • age between 18 and 45 (born 1969 - 1996)

Exclusion criteria

Exclusion Criteria:

  • also diagnosed with potentially functionally impairing neuromuscular, neurological or muscular disorders
  • insufficient Norwegian language skills
  • cognitive impairment
  • no sign of inflammation or bone erosions in the sacroiliac joints or in the spine on imaging
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
62 participants (actual)

Study arms

  • Experimental
    Physiotherapy follow-up

    Consultation at Physiotherapy-led Outpatient Clinic every 4 month.

    Other: Physiotherapy follow-up

  • No intervention
    Usual care

    Consultation every 4 months, twice a year by rheumatologist as usual, once a year by nurse.

Interventions

  • OtherPhysiotherapy follow-up

    Physiotherapy consultation every 4 months containing assessment of the spine and its mobility, including axial joints, assessment of the patients activity profile. Instruction in home-exercises and recommendations for optimization of activity profile. Information regarding the disease and the importance of physical activity and exercise.

06

What researchers measure

Primary outcomes

  1. Leeds Patient Satisfaction Questionnaire (LSQ)

    Time frame: 8 months

Secondary outcomes

  1. Bath Ankylosing Spondylitis Metrology Index (BASMI)

    Time frame: 8 months

  2. Bath Ankylosing Spondylitis Functional Index (BASFI)

    Time frame: 8 months

  3. Ankylosing Spondylitis Disease Activity Score (ASDAS)

    Time frame: 8 months

07

Study locations

1 site
  • Department of Rheumatology, Ålesund hospital
    Ålesund, 6026, Norway
08

References and documents

Publications

  • Holoyen PK, Stensdotter AK. Patients with spondyloarthritis are equally satisfied with follow-up by physiotherapist and rheumatologist. Musculoskeletal Care. 2018 Sep;16(3):388-397. doi: 10.1002/msc.1241. Epub 2018 Mar 24. PubMed 29573538 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2014 to primary completion in Apr 2015, 10 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2014
First posted
Mar 28, 2014
StartActual
Jun 2014
Primary completionActual
Apr 2015
CompletionActual
Apr 2015
Last update
Jun 9, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 9, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02098694
Lead sponsor
Norwegian University of Science and Technology
Collaborators
Helse Møre og Romsdal HF
Responsible party
Sponsor
First posted
Mar 28, 2014
Start date
Jun 2014
Primary completion
Apr 2015
Completion
Apr 2015
Last update
Jun 9, 2020

Study contacts

Ann-Katrin Stensdotter, PhD
principal investigator · Norwegian University of Science and Technology

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Spondylarthropathies →

Other studies from this sponsor

Norwegian University of Science and Technology →

Start the discussion